BIOGEN MA INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22376
 
  
 
C07K PEPTIDES 14529
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 50156
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 49118
 
  
 
C07D HETEROCYCLIC COMPOUNDS 35127
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3465
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 18120
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 16109
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1485
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 1060

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0037,939 METHODS AND COMPOSITIONS FOR DETECTING THERAPEUTIC NUCLEIC ACIDSFeb 11, 16Feb 08, 18[C12Q]
2018/0021,288 Neuroprotection in Demyelinating DiseasesJul 07, 17Jan 25, 18[A61K]
2018/0022,812 TREATMENT OF AUTOIMMUNE DISORDERS WITH CD154 ANTIBODIESApr 27, 15Jan 25, 18[C07K]
2018/0012,354 Methods For Improved Measurements Of Brain Volume and Changes In Brain VolumeJul 06, 17Jan 11, 18[G06T, A61B]
2017/0369,560 HUMAN ANTI-TAU ANTIBODIESFeb 08, 17Dec 28, 17[A61K, G01N, C07K]
2017/0360,699 APPARATUS FOR COMPOUND DISPERSIONDec 17, 15Dec 21, 17[A61K, A61H]
2017/0362,324 HUMANIZED ANTI-ALPHA V BETA 5 ANTIBODIES AND USES THEREOFSep 11, 15Dec 21, 17[C07K]
2017/0354,639 DITERPENOID DERIVATIVES AND METHODS OF USE THEREOFOct 23, 15Dec 14, 17[A61K, C07D]
2017/0355,729 METHODS AND COMPOSITIONS FOR CONTROLLING ANTIBODY AGGREGATIONDec 02, 15Dec 14, 17[A61K, C07K]
2017/0355,771 ANTI-GPIIB/IIIA ANTIBODIES AND USES THEREOFOct 23, 15Dec 14, 17[A61K, C12N, G01N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902774 Method for the treatment of inflammatory disordersSep 09, 13Feb 27, 18[A61K, C07K]
9902775 Anti-blood dendritic cell antigen 2 antibodies and uses thereofDec 10, 13Feb 27, 18[A61K, C07K]
9850206 S1P and/or ATX modulating agentsNov 20, 13Dec 26, 17[A61K, C07D]
9827258 Bicyclic aryl sphingosine 1-phosphate analogsJan 03, 17Nov 28, 17[A61K, C07F, C07D, C07C]
9808449 S1P modulating agentsDec 23, 15Nov 07, 17[A61K, C07D, C07K]
9809577 Biaryl inhibitors of Bruton's tyrosine kinaseDec 11, 14Nov 07, 17[C07D]
9809652 Methods of treating progressive forms of multiple sclerosis comprising subcutaneously administering daclizumabAug 08, 12Nov 07, 17[A61K, C07K]
9796780 LINGO-2 antagonists for treatment of conditions involving motor neuronsMay 14, 13Oct 24, 17[A61K, C07K]
9790229 Bruton's tyrosine kinase inhibitorsJan 25, 16Oct 17, 17[A61K, C07D]
9790533 Methods of preventing and removing trisulfide bondsFeb 06, 17Oct 17, 17[A61K, C12P, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0088,835 COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICINGAbandonedSep 16, 16Mar 30, 17[C12N]
2016/0354,465 Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of Lingo-1 Antagonists and TrkB AgonistsAbandonedMay 16, 16Dec 08, 16[A61K, C07K]
2016/0237,399 Control of Protein Glycosylation by Culture Medium Supplementation and Cell Culture Process ParametersAbandonedFeb 18, 15Aug 18, 16[C12P, C12N]
2016/0228,513 TREATMENT OF MELANOMA WITH INTERFERON-BETA AND RAS-RAF-MEK-ERK INHIBITOR COMBINATION THERAPYAbandonedOct 15, 15Aug 11, 16[A61K]
2016/0228,577 TRANSGENIC ANIMALS FOR IN VIVO IMAGINGAbandonedOct 15, 14Aug 11, 16[A61K, A01K]
2016/0213,745 USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATIONAbandonedDec 22, 15Jul 28, 16[A61K, C07K]
2016/0185,846 ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINSAbandonedJun 22, 15Jun 30, 16[C07K]
2016/0151,390 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)AbandonedDec 03, 15Jun 02, 16[A61K, C07K]
2016/0115,540 PRODRUGS AND DRUGSAbandonedMay 21, 14Apr 28, 16[A61K, C12Q, G01N]
2016/0101,157 METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMENAbandonedNov 09, 15Apr 14, 16[A61K]
2016/0083,468 Compositions Comprising Antibodies to Lingo or Fragments ThereofAbandonedJun 25, 15Mar 24, 16[A61K, C07K]
2016/0045,570 BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOFAbandonedJul 14, 15Feb 18, 16[A61K, G01N]
2016/0039,825 S1P AND/OR ATX MODULATING AGENTSAbandonedMar 14, 14Feb 11, 16[C07D]
2016/0017,041 TREATMENT AND PREVENTION OF ACUTE KIDNEY INJURY USING ANTI-ALPHA V BETA 5 ANTIBODIESAbandonedMar 13, 14Jan 21, 16[A61K, C07K]
2016/0002,329 TREATMENT OF CONDITIONS INVOLVING DEMYELINATIONAbandonedJun 09, 15Jan 07, 16[C07K]
2016/0002,743 HIGH RESOLUTION MELTING ANALYSIS ASSAY FOR THE DETECTION OF VIRAL DNAAbandonedMar 15, 14Jan 07, 16[C12Q]
2015/0361,417 ASSAY FOR DETECTION OF JC VIRUS DNAAbandonedJan 30, 14Dec 17, 15[C12Q, C12N]
2015/0353,929 COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICINGAbandonedDec 29, 14Dec 10, 15[C12N]
2015/0329,638 Use of DR6 Antagonists to Improve Motor Neuron DiseaseAbandonedDec 27, 13Nov 19, 15[A61K, C07K]
2015/0315,273 SP35 Antibodies And Uses ThereofAbandonedApr 02, 15Nov 05, 15[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.